Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.

Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.

Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is o...

An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...

Uncover six common misconceptions about self-pay pharmacies and learn why pharmacy benefit managers (PBMs) often provide more affordable, accessible, and clinically appropriate care.

Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...

Read the findings from Avalere Health's latest paper, “The Role of PBMs in the U.S. Healthcare System,” to learn how pharmacy benefit managers drive savings and unlock better health outcomes.